Last reviewed · How we verify
NCT05162287: CAPPS
Child and Adolescent Psychiatric Personality Structure
trial in Personality Disorders in 62 participants. Completed in 5 December 2022.
1 December 2022
Quick facts
| Lead sponsor | Universitätsklinikum Hamburg-Eppendorf |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 62 |
| Start date | 1 December 2021 |
| Primary completion | 1 December 2022 |
| Estimated completion | 5 December 2022 |
| Sites | 1 location across Germany |
Conditions studied
- Personality Disorders — all drugs for Personality Disorders →
- Social Withdrawal of Childhood or Adolescence — all drugs for Social Withdrawal of Childhood or Adolescence →
- Psychosocial Impairment — all drugs for Psychosocial Impairment →
Sponsor
Universitätsklinikum Hamburg-Eppendorf — full company profile →
Who can join
Adults 12 to 17, any sex, with Personality Disorders or Social Withdrawal of Childhood or Adolescence. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study plan outlined here represents an investigation of instruments on the patients treated in the acute ward of child and adolescent psychiatry at the University Medical Center Hamburg Eppendorf (UKE). The psychosocial burden of the affected children and adolescents is evident due to the severity of the disorders leading to specific admission. The psychosocial burden can be defined as "psychological, social, or school-occupational functional impairment \[...\] that has arisen as a consequence of a mental disorder, a specific developmental disorder, or an intellectual impairment". The current research project aims to survey the severity of psychosocial distress, personality functioning impairment, and social withdrawal. A better knowledge of these factors may contribute to a more suitable, specialized treatment offer on the acute ward in the medium term.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
"Alone Again, Naturally": Mental Health Problems, Level of Personality Functioning, Social Withdrawal and Loneliness in Adolescents Admitted as Acute Inpatients in the Aftermath of the COVID-19 Pandemic.
Boettcher J, Radzuweit D, Mey M, Rauch P, et al · · 2023 · cited 1× · PMID 38002834 · DOI 10.3390/children10111743
Verify or expand the search:
- PubMed search for NCT05162287
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Personality Disorders
Currently open trials in the same condition.
- NCT07082777 — Recovery in Telling Life Stories · NA · recruiting
- NCT07398365 — Medical Phenotyping of NHS General Adult Psychiatry (GAP) Inpatients · recruiting
- NCT06839950 — Sensory Profile and Early Clinical Signs of Calm Room Users · recruiting
- NCT06804369 — Benchmarking and Change Mechanisms in Personality Disorder Treatment · active not recruiting
- NCT06182787 — Development of a Model for Digital Monitoring of the Mental State of the Hospitalized Patient · recruiting
Other Universitätsklinikum Hamburg-Eppendorf trials
Trials by the same sponsor.
- NCT07443384 — Complications Associated With Radiofrequency Microneedling in Dermatology: a Delphi Consensus · not yet recruiting
- NCT07385092 — Continuous Vital Sign Monitoring Versus Routine Spot-checks in Patients After Non-cardiac Surgery · NA · recruiting
- NCT07009522 — Hamburg Emotion Awareness and Regulation Group Training for Autistic Adolescents (HEART) · EARLY_PHASE1 · not yet recruiting
- NCT07115394 — EEG Measurements to Capture DBS-induced Electric Potentials · recruiting
- NCT06955884 — Patient Experience of Transoral Versus Transnasal Awake Tracheal Intubation · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05162287 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universitätsklinikum Hamburg-Eppendorf
- Last refreshed: 19 July 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05162287.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing